Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

NCT00103974 is registered in ClinicalTrials.gov with Bayhill Therapeutics as lead sponsor.

NCT NCT00103974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00103974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis
Lead sponsor
Bayhill Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2004
Completion date
March 31, 2007
Enrollment
30
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis